The renal vasodilatory effect of prostaglandins is ameliorated in isolated-perfused kidneys of endotoxemic mice
- PMID: 30027346
- DOI: 10.1007/s00424-018-2183-3
The renal vasodilatory effect of prostaglandins is ameliorated in isolated-perfused kidneys of endotoxemic mice
Abstract
Endotoxemia-related acute kidney injury (AKI) is associated with increased formation of prostaglandins, which may serve as a compensatory mechanism to maintain renal function. We hypothesized that an increase of renal EP2 or EP4 receptors and/or a downregulation of renal EP1 and EP3 receptors enhances PGE2-induced renal vasodilatation. Injection of lipopolysaccharide (LPS; 3 mg/kg i.p.) increased microsomal prostaglandin E synthase (mPGES)-1 and prostacyclin synthase expression, whereas mPGES-2 expression was unaltered. Further, LPS increased the mRNA abundance for the prostaglandin EP4 receptor, whereas the expressions of the EP1 and EP3 receptors were decreased. In isolated-perfused kidneys from control mice, PGE2 exerted a dual effect on renal vascular tone, inducing vasodilatation at lower concentrations and vasoconstriction at higher concentrations. In kidneys from endotoxemic mice, the vasodilatory component was more pronounced, whereas the vasoconstriction at higher PGE2 concentrations was absent. Similarly, prostacyclin (PGI2)-induced vasodilatation was more pronounced in endotoxemic kidneys. The enhanced vasodilatory effect was paralleled by an increase in renal vascular EP4 and prostacyclin IP receptor mRNA expression. Further, stimulation of renin secretion rate by PGE2 and PGI2 was enhanced in endotoxemic kidneys. Pretreatment with the cyclooxygenase (COX)-2 inhibitor SC-236 (10 mg/kg) did not alter the basal GFR, but augmented the LPS-induced decline in GFR, and attenuated the LPS-induced increase in plasma renin concentration in vivo. Our data suggest that an activation of the COX-2/mPGES-1 synthetic pathway is responsible for the increased renal formation of PGE2 in response to LPS and that the vasodilatory effect of PGE2 and PGI2 is enhanced during endotoxemia.
Keywords: Cyclooxygenase; Endotoxemia; Prostacyclin; Prostaglandin; Renal vascular tone; Renin.
Similar articles
-
Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.Am J Physiol Renal Physiol. 2004 Sep;287(3):F427-33. doi: 10.1152/ajprenal.00072.2004. Epub 2004 Apr 27. Am J Physiol Renal Physiol. 2004. PMID: 15113745
-
Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.J Am Soc Nephrol. 2005 Aug;16(8):2354-62. doi: 10.1681/ASN.2004070556. Epub 2005 Jun 23. J Am Soc Nephrol. 2005. PMID: 15976003
-
Prostacyclin in endotoxemia-induced acute kidney injury: cyclooxygenase inhibition and renal prostacyclin synthase transgenic mice.Am J Physiol Renal Physiol. 2007 Oct;293(4):F1131-6. doi: 10.1152/ajprenal.00212.2007. Epub 2007 Jul 25. Am J Physiol Renal Physiol. 2007. PMID: 17652370
-
Renal prostaglandins E2 and I2. Aspects of metabolism, and relationship to renal hemodynamics and renin release mechanisms.J Oslo City Hosp. 1989 Nov-Dec;39(11-12):123-36. J Oslo City Hosp. 1989. PMID: 2693665 Review.
-
Prostaglandin receptors: their role in regulating renal function.Curr Opin Nephrol Hypertens. 2000 Jan;9(1):23-9. doi: 10.1097/00041552-200001000-00005. Curr Opin Nephrol Hypertens. 2000. PMID: 10654821 Review.
Cited by
-
Renal ischemia-reperfusion injury impairs renal calcium, magnesium, and phosphate handling in mice.Pflugers Arch. 2019 Jun;471(6):901-914. doi: 10.1007/s00424-019-02255-6. Epub 2019 Jan 26. Pflugers Arch. 2019. PMID: 30685787
-
Deregulated renal magnesium transport during lipopolysaccharide-induced acute kidney injury in mice.Pflugers Arch. 2019 Apr;471(4):619-631. doi: 10.1007/s00424-019-02261-8. Epub 2019 Feb 6. Pflugers Arch. 2019. PMID: 30726531
-
Role of protease-activated receptor 2 in regulation of renin synthesis and secretion in mice.Naunyn Schmiedebergs Arch Pharmacol. 2019 Nov;392(11):1401-1410. doi: 10.1007/s00210-019-01677-4. Epub 2019 Jun 27. Naunyn Schmiedebergs Arch Pharmacol. 2019. PMID: 31243492
-
Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition.Front Pharmacol. 2024 Mar 8;15:1365802. doi: 10.3389/fphar.2024.1365802. eCollection 2024. Front Pharmacol. 2024. PMID: 38523633 Free PMC article. Review.
-
Prostaglandin E1 prevents histopathological changes improving renal function in experimental nephropathy induced by renal microembolism.Int J Clin Exp Pathol. 2020 Jul 1;13(7):1624-1632. eCollection 2020. Int J Clin Exp Pathol. 2020. PMID: 32782681 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials